Physician

David S. Mckinsey, M.D.

According to 2025 Medicare claims, David Mckinsey, M.D. (NPI: 1366405078) practices infectious disease in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is METRO INFECTIOUS DISEASE CONSULTANTS, LLC (NPI: 1235125717; TIN: 363966745) and primary practice location at 66211-1313. Mckinsey is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Mckinsey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 601 traditional Medicare patients, billed 76,574 HCPCS/CPT codes, and received $869,381 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 927 prescription claims across 115 beneficiaries totaling $1,723,594 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). Open Payments data shows 2 records totaling $35. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $235,655 to $869,381. Similarly, Part D prescription costs have risen steadily, from $930,389 to $1,723,594. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.